BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,096 filers reported holding BAXTER INTL INC in Q4 2020. The put-call ratio across all filers is 0.87 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $3,044,920 | +127.2% | 75,072 | +201.8% | 0.13% | +98.4% |
| Q3 2022 | $1,340,000 | -20.0% | 24,872 | -4.6% | 0.06% | -14.7% |
| Q2 2022 | $1,675,000 | +58.0% | 26,072 | +90.7% | 0.08% | +92.3% |
| Q1 2022 | $1,060,000 | +289.7% | 13,672 | +331.0% | 0.04% | +290.0% |
| Q4 2021 | $272,000 | +1.5% | 3,172 | -4.9% | 0.01% | 0.0% |
| Q3 2021 | $268,000 | -0.4% | 3,336 | 0.0% | 0.01% | 0.0% |
| Q2 2021 | $269,000 | -4.3% | 3,336 | 0.0% | 0.01% | 0.0% |
| Q1 2021 | $281,000 | +1.1% | 3,336 | -3.8% | 0.01% | -16.7% |
| Q4 2020 | $278,000 | -0.4% | 3,467 | 0.0% | 0.01% | 0.0% |
| Q3 2020 | $279,000 | -10.0% | 3,467 | -3.8% | 0.01% | -29.4% |
| Q2 2020 | $310,000 | +5.8% | 3,605 | 0.0% | 0.02% | -19.0% |
| Q1 2020 | $293,000 | -41.6% | 3,605 | -40.0% | 0.02% | -25.0% |
| Q4 2019 | $502,000 | -14.0% | 6,005 | -10.1% | 0.03% | -17.6% |
| Q3 2019 | $584,000 | -85.8% | 6,680 | -86.7% | 0.03% | -85.7% |
| Q2 2019 | $4,118,000 | -97.3% | 50,280 | +298.5% | 0.24% | -61.3% |
| Q1 2019 | $155,180,000 | +1460.5% | 12,618 | -91.6% | 0.61% | -9.5% |
| Q4 2018 | $9,944,000 | -14.7% | 151,080 | -0.1% | 0.68% | +1.7% |
| Q3 2018 | $11,654,000 | +39.3% | 151,180 | +33.4% | 0.66% | +27.9% |
| Q2 2018 | $8,367,000 | -15.0% | 113,306 | -25.1% | 0.52% | -19.5% |
| Q1 2018 | $9,841,000 | +47.4% | 151,306 | +46.5% | 0.65% | +50.6% |
| Q4 2017 | $6,678,000 | +56.7% | 103,306 | +52.1% | 0.43% | +49.0% |
| Q3 2017 | $4,261,000 | +1009.6% | 67,906 | +971.9% | 0.29% | +966.7% |
| Q2 2017 | $384,000 | +17.4% | 6,335 | +0.5% | 0.03% | +17.4% |
| Q1 2017 | $327,000 | -84.7% | 6,306 | -86.9% | 0.02% | -85.9% |
| Q4 2016 | $2,138,000 | -6.8% | 48,212 | 0.0% | 0.16% | -15.1% |
| Q3 2016 | $2,295,000 | +5.0% | 48,212 | -0.2% | 0.19% | -0.5% |
| Q2 2016 | $2,186,000 | +6.4% | 48,331 | -3.4% | 0.19% | +3.8% |
| Q1 2016 | $2,054,000 | +6.6% | 50,012 | -1.0% | 0.19% | 0.0% |
| Q4 2015 | $1,927,000 | +16.2% | 50,512 | 0.0% | 0.19% | +1.6% |
| Q3 2015 | $1,659,000 | -54.6% | 50,512 | -3.3% | 0.18% | -51.6% |
| Q2 2015 | $3,651,000 | +2.1% | 52,212 | 0.0% | 0.38% | -2.1% |
| Q1 2015 | $3,577,000 | -9.1% | 52,212 | -2.8% | 0.39% | -15.9% |
| Q4 2014 | $3,937,000 | +0.1% | 53,712 | -2.0% | 0.46% | -13.2% |
| Q3 2014 | $3,934,000 | +1.1% | 54,812 | +1.9% | 0.53% | -2.6% |
| Q2 2014 | $3,891,000 | +5.9% | 53,812 | +7.8% | 0.54% | +0.9% |
| Q1 2014 | $3,673,000 | +5.8% | 49,912 | 0.0% | 0.54% | +2.5% |
| Q4 2013 | $3,471,000 | +5.9% | 49,912 | 0.0% | 0.52% | -4.4% |
| Q3 2013 | $3,279,000 | -5.1% | 49,912 | 0.0% | 0.55% | -13.0% |
| Q2 2013 | $3,457,000 | – | 49,912 | – | 0.63% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SECTOR GAMMA AS | 713,500 | $49,895,000 | 12.74% |
| Veritas Asset Management LLP | 7,636,450 | $534,017,000 | 7.53% |
| FIRST NEW YORK SECURITIES LLC /NY | 154,158 | $10,780,269,000 | 5.40% |
| Gabalex Capital Management LLC | 200,000 | $14,981,000 | 5.39% |
| Veritas Investment Management LLP | 291,825 | $18,816,000 | 5.32% |
| Tweedy, Browne Co LLC | 2,543,966 | $177,900,000 | 4.91% |
| York Capital Management Global Advisors, LLC | 8,074,375 | $564,641,000 | 4.78% |
| First Fiduciary Investment Counsel, Inc. | 270,675 | $18,928,000 | 4.10% |
| SCHARF INVESTMENTS, LLC | 2,247,225 | $157,148,000 | 4.03% |
| Osher Van de Voorde Investment Management | 96,235 | $6,730,000 | 3.91% |